Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Acute Monoblastic Leukemia
Symptoms, Doctors, Treatments, Advances & More
Overview
Find a Doctor
Latest Advances
Clinical Trials
Condition 101
About Acute Monoblastic Leukemia
What are the alternative names for Acute Monoblastic Leukemia?
Acute myeloblastic leukemia type 5
Acute monocytic leukemia
AML-M5
AML M5
Top Global Doctors
For Acute Monoblastic Leukemia
Bookmark
Click to see options
XT
Elite
Xavier G. Thomas
Pierre-la-treiche, FR
Bookmark
Click to see options
RS
Elite
Richard M. Stone
Hematology
Oncology
Internal Medicine
Boston, MA
Bookmark
Click to see options
EE
Elite
Elihu H. Estey
Oncology
Hematology
Internal Medicine
Seattle, WA
Bookmark
Click to see options
MT
Elite
Martin S. Tallman
Oncology
Hematology
Internal Medicine
New York, NY
Bookmark
Click to see options
AB
Elite
Alan K. Burnett
Cardiff, WLS, GB
Bookmark
Click to see options
TK
Elite
Tapan M. Kadia
Oncology
Hematology
Internal Medicine
Houston, TX
Latest Advances
On Acute Monoblastic Leukemia
Condition:
Acute Monocytic Leukemia
Journal:
Zhongguo shi yan xue ye xue za zhi
Treatment Used:
Allogeneic Hematopoietic Stem Cell Transplantation
Number of Patients:
71
Published —
December 07, 2020
The study researched the outcomes of allogeneic hematopoietic stem cell transplantation for treating acute monocytic leukemia.
Condition:
Hemophagocytic Lymphohistiocytosis (HLH) from Acute Monocytic Leukemia after Chemotherapy
Journal:
Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
Treatment Used:
Chemotherapy
Number of Patients:
1
Published —
July 09, 2020
This case report describes a patient with HLH from acute monocytic leukemia after chemotherapy that was treated with further chemotherapy.
Clinical Trials
For Acute Monoblastic Leukemia
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Other, Drug, Radiation, Procedure, Biological
Participants:
240
Start Date:
June 1, 2021
A Randomized Phase II Study to Compare ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Behavioral
Participants:
20
Start Date:
May 31, 2021
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome